Association between physical functions and quality of life in sarcoidosis

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 31, Issue 2, 2014, Pages 117-128

  Marcellis, R G J ^a   Lenssen, A F ^a   Drent, M ^b,c   De Vries, J ^d,e  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GELDERSE VALLEI HOSPITAL   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

^e TILBURG UNIVERSITY   (Netherlands)

Author keywords

Exercise capacity; Fatigue; Muscle strength; Quality of life; Sarcoidosis

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EXERCISE; FATIGUE; FATIGUE ASSESSMENT SCALE; FEMALE; FLEXOR MUSCLE; FOLLOW UP; HAMSTRING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; QUALITY OF LIFE; SARCOIDOSIS; SCORING SYSTEM; WORLD HEALTH ORGANIZATION; CASE CONTROL STUDY; DISEASE COURSE; EXERCISE TEST; EXERCISE TOLERANCE; HEALTH STATUS; LUNG; LUNG FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; PSYCHOLOGY; QUESTIONNAIRE; SKELETAL MUSCLE; TIME FACTOR; TORQUE;

ADULT; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; EXERCISE TEST; EXERCISE TOLERANCE; FATIGUE; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; LUNG; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE, SKELETAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS; SARCOIDOSIS; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; TORQUE;

EID: 84907338558     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Statement on sarcoidosis. Joint Statement of the AmericanThoracic Society (ATS), the European Respiratory Society (ERS) and theWorldAssociation of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit CareMed; 160: 736-755
2. Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY,Muller-Quernheim J. Sarcoidosis. Lancet 2014; 383: 1155-1167
3. Marcellis RGJ, Lenssen AF, Kleynen S, De Vries J, Drent M. Exercise capacity, muscle strength and fatigue in sarcoidosis: a follow-up study. Lung 2013; 191: 247-256
4. Cremers JP,DrentM,ElfferichMD et al.Body composition profiling in aDutch sarcoidosis population. SarcoidosisVascDiffuse LungDis 2013; 30: 289-299
5. Wirnsberger RM, de Vries J, Breteler MH, van Heck GL,Wouters EF, DrentM.Evaluation of quality of life in sarcoidosis patients.RespirMed 1998; 92: 750-756
6. De Vries J,Michielsen H, Van Heck GL, Drent M.Measuring fatigue in sarcoidosis: the Fatigue Assessment Scale (FAS). Br J Health Psychol 2004; 9: 279-291
7. Alilovic M, Peros-Golubicic T,Radosevic-Vidacek B et al.WHOQOLBREF questionnaire as a measure of quality of life in sarcoidosis. Coll Antropol 2013; 37: 701-706
8. Baughman RP,Drent M,Culver DA et al.Endpoints for clinical trials of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2012; 29: 90-98
9. De Vries J,Wirnsberger RM. Fatigue, quality of life and health status in sarcoidosis. Eur RespirMon 2005; 32: 92-104
10. Steiner WA,Ryser L,Huber E,Uebelhart D,Aeschlimann A, Stucki G. Use of the ICF model as a clinical problem-solving tool in physical therapy and rehabilitation medicine. Phys Ther 2002; 82: 1098-1107
11. Spruit MA,Thomeer MJ,Gosselink R et al. Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status.Thorax 2005; 60: 32-38
12. Michielsen HJ,Drent M, Peros-Golubicic T,De Vries J. Fatigue is associated with quality of life in sarcoidosis patients. Chest 2006; 130: 989-994
13. Michielsen HJ, Peros-Golubicic T, Drent M, De Vries J. Relationship between symptoms and quality of life in a sarcoidosis population. Respiration 2007; 74: 401-405
14. Baughman RP, Sparkman BK, Lower EE. Six-minute walk test and health status assessment in sarcoidosis. Chest 2007; 132: 207-213
15. Bourbonnais JM,Malaisamy S, Dalal BD, Samarakoon PC, Parikh SR, Samavati L. Distance saturation product predicts health-related quality of life among sarcoidosis patients.Health Qual Life Outcomes 2012; 10: 67
16. Wirnsberger RM,DrentM,HekelaarN et al.Relationship between respiratory muscle function and quality of life in sarcoidosis. Eur Respir J 1997; 10: 1450-1455
17. Brancaleone P, Perez T, Robin S, Neviere R,Wallaert B. Clinical impact of inspiratory muscle impairment in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21: 219-227
18. Cox CE, Donohue JF, Brown CD, Kataria YP, Judson MA. Health-related quality of life of persons with sarcoidosis. Chest 2004; 125: 997-1004
19. De Vries J,DrentM.Quality of life and health status in sarcoidosis: a review of the literature. Clin ChestMed 2008; 29: 525-532
20. Marcellis RG, Lenssen AF, ElfferichMD et al. Exercise capacity,muscle strength and fatigue in sarcoidosis. Eur Respir J 2011; 38: 628-634
21. Quanjer PH,Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests,European community for steel and coal.Official statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16: 5-40
22. Rothkrantz-Kos S, van Dieijen-Visser MP, Mulder PG, Drent M. Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis. Clin Chem 2003; 49: 1510-1517
23. WHO. Development of the World Health Organization WHOQOLBREF quality of life assessment.TheWHOQOL Group. PsycholMed 1998; 28: 551-558
24. Trompenaars FJ,Masthoff ED,VanHeck GL,Hodiamont PP,De Vries J. Content validity, construct validity, and reliability of theWHOQOL Bref in a population of Dutch adult psychiatric outpatients. Qual Life Res 2005; 14: 151-160
25. O'Carroll RE, Smith K, CoustonM, Cossar JA,Hayes PC. A comparison of the WHOQOL-100 and the WHOQOL-BREF in detecting change in quality of life following liver transplantation. Qual Life Res 2000; 9: 121-124
26. MichielsenHJ,De Vries J,VanHeck GL,Van de Vijver FJR, Sijtsma K. Examination of the dimensionality of fatigue: The construction of the Fatigue Assessment Scale (FAS). EJPA 2004; 20: 39-48
27. ATS. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit CareMed 2002; 166: 111-117
28. Freedson PS, Gilliam TB, Mahoney T, Maliszewski MA, Kastango K. Industrial torque levels by age group and gender. Isokinet Exerc Sci 1993; 3: 34-42
29. Drouin JM, Valovich-mcLeod TC, Shultz SJ, Gansneder BM, Perrin DH. Reliability and validity of the Biodex system 3 pro isokinetic dynamometer velocity, torque and position measurements. Eur J Appl Physiol 2004; 91: 22-29
30. McCleary RW, Andersen JC. Test-retest reliability of reciprocal isokinetic knee extension and flexion peak torque measurements. J Athl Train 1992; 27: 362-365
31. Bohannon RW. Make tests and break tests of elbow flexor muscle strength. Phys Ther 1988; 68: 193-194
32. Bohannon RW, Andrews AW. Interrater reliability of hand-held dynamometry. Phys Ther 1987; 67: 931-933
33. Black LF, Hyatt RE. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis 1969; 99 696-702
34. Harik-Khan RI,Wise RA, Fozard JL.Determinants of maximal inspiratory pressure.The Baltimore Longitudinal Study of Aging. Am J Respir Crit CareMed 1998; 158: 1459-1464
35. McCrum-Gardner E. Which is the correct statistical test to use? Br J OralMaxillofac Surg 2008; 46: 38-41
36. Wirnsberger RM, de Vries J,Wouters EF, Drent M. Clinical presentation of sarcoidosis in The Netherlands an epidemiological study. Neth J Med 1998; 53: 53-60
37. De Vries J,Rothkrantz-Kos S, van Dieijen-VisserMP,DrentM.The relationship between fatigue and clinical parameters in pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21: 127-136
38. Drent M, Lower EE, De Vries J. Sarcoidosis-Associated fatigue. Eur Respir J 2012; 40: 255-263
39. De Kleijn WP, De Vries J, Lower EE, Elfferich MD, Baughman RP, Drent M. Fatigue in sarcoidosis: a systematic review. Curr Opin Pulm Med 2009; 15: 499-506
40. De Kleijn WP, De Vries J, Wijnen PA, Drent M. Minimal (clinically) important differences for the Fatigue Assessment Scale in sarcoidosis. RespirMed 2011; 105: 1388-1395
41. Kabitz HJ, Lang F,Walterspacher S, Sorichter S,Muller-Quernheim J, WindischW. Impact of impaired inspiratorymuscle strength on dyspnea and walking capacity in sarcoidosis. Chest 2006; 130: 1496-1502
42. Patel AS, Siegert RJ, Creamer D et al. The development and validation of the King's Sarcoidosis Questionnaire for the assessment of health status. Thorax 2013; 68: 57-65
43. Braam AW, de Haan SN, Vorselaars AD et al. Influence of repeated maximal exercise testing on biomarkers and fatigue in sarcoidosis. Brain Behav Immun 2013; 33: 57-64
44. Heij L,NiestersM, SwartjesMet al. Safety and Efficacy of ARA 290 in Sarcoidosis Patients with Symptoms of Small FiberNeuropathy: A Randomized, Double-Blind Pilot Study.MolMed 2013; 18: 1430-1436
45. SpruitMA,Wouters EFM, Gosselink R. Rehabilitation programmes in sarcoidosis: a multidisciplinary approach. Eur Respir J 2005; 32: 316-326
46. Huppmann P, Sczepanski B, BoenschMet al. Effects of in-patient pulmonary rehabilitation in patients with interstitial lung disease.Eur Respir J 2013; 42: 444-453:
47. Salhi B, Troosters T, Behaegel M, Joos G, Derom E. Effects of pulmonary rehabilitation in patients with restrictive lung diseases. Chest 2010; 137: 273-279
48. Kozu R, Senjyu H, Jenkins SC,Mukae H, Sakamoto N, Kohno S. Differences in response to pulmonary rehabilitation in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease.Respiration 2011; 81: 196-205